InvestorsHub Logo

Paleman

04/14/16 10:56 AM

#8143 RE: Turney #8141

Re Cel-Sci and M. D. Anderson: three years ago at the annual meeting I asked Geert if Anderson was participating in the phase III trial and the answer at that time was "no." Anderson is currently very involved in immunotherapy research/development so perhaps now there may be some inter-action with Cel-Sci.